Business
Earth Science Tech, Inc. Announces New Agreement with Axcelon Biopolymers Corp. for Distribution of Nanoderm™ Medical Device & Advances with Its MSN-2 Medical Device
Earth Science Tech, Inc. Announces New Agreement with Axcelon Biopolymers Corp. for Distribution of Nanoderm™ Medical Device & Advances with Its MSN-2 Medical Device.
About this update from Earth Science Tech, Inc.
[{"type":"text","content":"\n\n Doral, FL, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK: ETST) (\"ETST\" or \"the Company\"), an innovative biotech company that operates in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical, medical device, research and development, has signed an agreement with Axcelon Biopolymers Corp for the exclusive distribution of their Nanoderm™ Biopolymer products in Morocco and Djibouti, which was hinted in the beginning of August. \n NanodermTM is a unique wound care product, which is used by hospitals, clinics, and the general public for a variety of wound treatments, including burns, scratches, and more serious wounds like diabetic foot ulcers. It is also excellent for soldiers during missions. Unlike regular bandages, Nanoderm™ is applied only once over most wounds, where it remains for the duration of the healing process. It provides a barrier to infections, while allowing air to pass through. This promotes healing and reduces pain. For these reasons, active consumers and travelers enjoy the flexibility of the treatment. As the exclusive distributor in the two mentioned countries, ETST will be marketing two medical devices at the same time; the MSN-2 medical device for STI testing and the Nanoderm™ product. “We are very proud to launch Nanoderm™ products in countries where we are planning to introduce our innovative MSN-2 medical device through Earth Science Pharmaceutical, Inc.,” said CEO & CSO, Dr. Michel Aubé, “This will allow for the development of cost-sharing promotion plans. Axcelon products are already certified for sale among Canada and many other countries. We are working to expand the distribution exclusivities mostly in already industrialized countries” View Nanoderm’s website for more information on the product. Advances in MSN-2 Project, New Canadian filial created                                                                                                                          &...